CD5 and skin neoplasm: Though STAT3 activation and CD5+ B cell proportion are correlated with poor outcomes in B16 skin tumor cell lines (93, 94), adoptive transfer of activated B cells in tumor cell inoculated mice leads to slower tumor growth (95).